Prohibitin mutations are uncommon in prostate cancer families linked to chromosome 17q

This publication has 15 references indexed in Scilit:

• A Combined Genomewide Linkage Scan of 1,233 Families for Prostate Cancer–Susceptibility Genes Conducted by the International Consortium for Prostate Cancer Genetics
  American Journal of Human Genetics, 2005
• Prohibitin: a potential target for new therapeutics
  Trends in Molecular Medicine, 2005
• Truncating BRCA1 Mutations Are Uncommon in a Cohort of Hereditary Prostate Cancer Families with Evidence of Linkage to 17q Markers
  Clinical Cancer Research, 2004
• Combined Genome-Wide Scan for Prostate Cancer Susceptibility Genes
  JNCI Journal of the National Cancer Institute, 2004
• Androgens target prohibitin to regulate proliferation of prostate cancer cells
  Oncogene, 2004
• The complex genetic epidemiology of prostate cancer
  Human Molecular Genetics, 2004
• Where are the prostate cancer genes?—A summary of eight genome wide searches
  The Prostate, 2003
• Genome‐wide scan for prostate cancer susceptibility genes using families from the University of Michigan prostate cancer genetics project finds evidence for linkage on chromosome 17 near BRCA1
  The Prostate, 2003
• Prohibitin: Potential role in senescence, development, and tumor suppression
  Experimental Gerontology, 1995
• The Human Prohibitin (PHB) Gene Family and Its Somatic Mutations in Human Tumors
  Genomics, 1993